Abstract
Patients with diabetes mellitus (DM) are at increased risk for heart failure regardless of ejection fraction. We assessed the relationship between DM and cardiac structure and function, and response to therapy with the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction (HFpEF).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
